Catégories
Documents disponibles dans cette catégorie (76)
Ajouter le résultat dans votre panier
Visionner les documents numériques
Faire une suggestion Affiner la recherche
Etendre la recherche sur niveau(x) vers le bas
Document de travail
S. GRIFFIN ; F. FUSCO ; B. NAIDOO ; et al. ; University of York. Centre for Health Economics. (C.H.E.). York. GBR | York : University of York | 2020Cost-effectiveness analysis (CEA) plays a key role informing decision-making in healthcare and, consequently, the interpretation of its results is discussed in formal guidance from health technology assessment (HTA) organisations. A body of rese[...]
Document de travail
S. HINDE ; S. WALKER ; H. LORTIE-FORGUES ; University of York. Centre for Health Economics. (C.H.E.). York. GBR | York : University of York | 2019In a UK policy context, education and healthcare sectors share many characteristics; however, the role of economic evaluation in informing policy making is very different. While in health it has become a key part of the deliberative processes of[...]
Ouvrage
C. ALLARD ; B. RICKEY ; Agence Nouvelle des Solidarités Actives. (A.N.S.A.). Paris. FRA ; France Stratégie. Paris. FRA ; et al. | Paris : A.N.S.A. | 2017Partant du principe qu’il faut du temps et des moyens pour amener « la preuve » au cœur de l’action publique, le gouvernement britannique a soutenu ces dernières années le développement de structures dédiées au transfert de la connaissance – not[...]
Document de travail
Haut Conseil pour l'Avenir de l'Assurance Maladie. (H.C.A.A.M.). Paris. FRA | Paris : H.C.A.A.M. | 2016La contrainte financière pèse de plus en plus fortement sur le système de santé (arrivé à maturité en termes notamment de couverture de la population) sous l’effet du vieillissement et de l’arrivée d’innovations coûteuses qui engendrent une croi[...]
Document de travail
E. BROCKIS ; G. MARSDEN ; A. COLE ; et al. ; Office of Health Economics. (O.H.E.). Londres. GBR | Londres : O.H.E. | 2016Background: All NICE decisions exert an influence on the allocation of fixed NHS budgets, but decisions for different types of health interventions (for example drugs and devices) are handled via different ‘programmes’ within NICE. These differe[...]
Bulletin : Fascicule
HEALTH TECHNOLOGY ASSESSMENT, 19 Num 4 - 01/01/2015 - Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold.
K. CLAXTON ; S. MARTIN ; M. SOARES | 2015Cost-effectiveness analysis involves the comparison of the incremental cost-effectiveness ratio of a new technology, which is more costly than existing alternatives, with the cost-effectiveness threshold. This indicates whether or not the health[...]
Ouvrage
This guideline covers the transition between inpatient hospital settings and community or care homes for adults with social care needs. It aims to improve people's experience of admission to, and discharge from, hospital by better coordination o[...]
Congrès
On 22 September 2015, OHE’s Koonal Shah gave a seminar at the Institute of Health Policy & Management, Erasmus University Rotterdam. Koonal’s presentation reported research conducted in collaboration with Professors Aki Tsuchiya and Allan Wailoo[...]
Ouvrage
La loi de finance de la Sécurité Sociale pour 2012 instaure l’évaluation médico-économique comme l’un des déterminants du prix des produits de santé revendiquant le remboursement en tant que produit innovant et ayant un impact significatif sur l[...]
Document de travail
K. CLAXTON ; S. MARTIN ; M. SOARES ; et al. ; University of York. Centre for Health Economics. (C.H.E.). York. GBR | York : University of York | 2013This study aimed to develop methods to estimate the NICE cost-effectiveness threshold making use of routinely available data. The methods used in this study provide an empirically-based and explicit quantification of the scale of opportunity cos[...]
Document de travail
H. DAKIN ; N. DEVLIN ; Y. FENG ; et al. ; University of York. Centre for Health Economics. (C.H.E.). York. GBR | York : University of York | 2013Background: The National Institute for Health and Care Excellence (NICE) emphasises that costeffectiveness is not the only consideration in health technology appraisal and is increasingly explicit about other factors considered relevant. Observi[...]
Ouvrage
N. MATTISON, Editeur commercial ; Office of Health Economics. (O.H.E.). Londres. GBR, Editeur commercial ; Office of Health Economics. (O.H.E.). Londres. GBR, Editeur commercial ; Association of the British Pharmaceutical Industry. (A.B.P.I.). Londres. GBR, Editeur commercial | Londres : O.H.E. | 2013The conference reported in this publication was held in October 2012 to celebrate the 50th anniversary of the Office of Health Economics (OHE). In keeping with the spirit of this organisation's long history, the conference's intent was to identi[...]
Document de travail
M. DRUMMOND ; University of York. Centre for Health Economics. (C.H.E.). York. GBR | York : University of York | 2012The objective of this paper is to examine the impact of economic evaluation on the reimbursement process for pharmaceuticals. Before the introduction of economic evaluation, a range of arrangements existed across different jurisdictions, varying[...]
Document de travail
K. SHAH ; A. TSUCHIYA ; A. RISA HOLE ; et al. ; Office of Health Economics. (O.H.E.). Londres. GBR | 2012In 2009, the UK's National Institute for Health and Clinical Excellence (NICE) issued supplementary advice that its Appraisal Committees are to consider when assessing treatments that extend life at the end of life. This includes an option for a[...]
Ouvrage
B. RUMBOLD ; V. ALAKESON ; P. SMITH ; Nuffield Trust. Londres. GBR | Londres : Nuffield Trust | 2012Political debates over the Secretary of State’s duty to provide a comprehensive health service have again thrown a spotlight on how the NHS interprets national guidance at a local level. Clearly some fear that devolving more responsibility to lo[...]
